1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Zn2+ entry through the mitochondrial calcium uniporter is a critical contributor to mitochondrial dysfunction and neurodegeneration

      , ,
      Experimental Neurology
      Elsevier BV

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          <p class="first" id="P1">Excitotoxic Ca <sup>2+</sup> accumulation contributes to ischemic neurodegeneration, and Ca <sup>2+</sup> can enter the mitochondria through the mitochondrial calcium uniporter ( <b>MCU</b>) to promote mitochondrial dysfunction. Yet, Ca <sup>2+</sup>-targeted therapies have met limited success. A growing body of evidence has highlighted the underappreciated importance of Zn <sup>2+</sup>, which also accumulates in neurons after ischemia and can induce mitochondrial dysfunction and cell death. While studies have indicated that Zn <sup>2+</sup> can also enter the mitochondria through the MCU, the specificity of the pore’s role in Zn <sup>2+</sup>-triggered injury is still debated. Present studies use recently available MCU knockout mice to examine how the deletion of this channel impacts deleterious effects of cytosolic Zn <sup>2+</sup> loading. In cultured cortical neurons from MCU knockout mice, we find significantly reduced mitochondrial Zn <sup>2+</sup> accumulation. Correspondingly, these neurons were protected from both acute and delayed Zn <sup>2+</sup>-triggered mitochondrial dysfunction, including mitochondrial reactive oxygen species generation, depolarization, swelling and inhibition of respiration. Furthermore, when toxic extramitochondrial effects of Ca <sup>2+</sup> entry were moderated, both cultured neurons (exposed to Zn <sup>2+</sup>) and CA1 neurons of hippocampal slices (subjected to prolonged oxygen glucose deprivation to model ischemia) from MCU knockout mice displayed decreased neurodegeneration. Finally, to examine the therapeutic applicability of these findings, we added an MCU blocker after toxic Zn <sup>2+</sup> exposure in wildtype neurons (to induce postinsult MCU blockade). This significantly attenuated the delayed evolution of both mitochondrial dysfunction and neurotoxicity. These data—combining both genetic and pharmacologic tools—support the hypothesis that Zn <sup>2+</sup> entry through the MCU is a critical contributor to ischemic neurodegeneration that could be targeted for neuroprotection. </p>

          Related collections

          Most cited references70

          • Record: found
          • Abstract: not found
          • Article: not found

          Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The physiological role of mitochondrial calcium revealed by mice lacking the mitochondrial calcium uniporter (MCU)

            Mitochondrial calcium has been postulated to regulate a wide range of processes from bioenergetics to cell death. Here, we characterize a mouse model that lacks expression of the recently discovered mitochondrial calcium uniporter (MCU). Mitochondria derived from MCU-/- mice have no apparent capacity to rapidly uptake calcium. While basal metabolism appears unaffected, the skeletal muscle of MCU-/- mice exhibited alterations in the phosphorylation and activity of pyruvate dehydrogenase. In addition, MCU-/- mice exhibited marked impairment in their ability to perform strenuous work. We further show that mitochondria from MCU-/- mice lacked evidence for calcium-induced permeability transition pore (PTP) opening. The lack of PTP opening does not appear to protect MCU-/- cells and tissues from cell death, although MCU-/- hearts fail to respond to the PTP inhibitor cyclosporin A (CsA). Taken together, these results clarify how acute alterations in mitochondrial matrix calcium can regulate mammalian physiology.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease.

              Mitochondrial dysfunction has been proposed to play a pivotal role in neurodegenerative diseases, including Alzheimer's disease (AD). To address whether mitochondrial dysfunction precedes the development of AD pathology, we conducted mitochondrial functional analyses in female triple transgenic Alzheimer's mice (3xTg-AD) and age-matched nontransgenic (nonTg). Mitochondrial dysfunction in the 3xTg-AD brain was evidenced by decreased mitochondrial respiration and decreased pyruvate dehydrogenase (PDH) protein level and activity as early as 3 months of age. 3xTg-AD mice also exhibited increased oxidative stress as manifested by increased hydrogen peroxide production and lipid peroxidation. Mitochondrial amyloid beta (Abeta) level in the 3xTg-AD mice was significantly increased at 9 months and temporally correlated with increased level of Abeta binding to alcohol dehydrogenase (ABAD). Embryonic neurons derived from 3xTg-AD mouse hippocampus exhibited significantly decreased mitochondrial respiration and increased glycolysis. Results of these analyses indicate that compromised mitochondrial function is evident in embryonic hippocampal neurons, continues unabated in females throughout the reproductive period, and is exacerbated during reproductive senescence. In nontransgenic control mice, oxidative stress was coincident with reproductive senescence and accompanied by a significant decline in mitochondrial function. Reproductive senescence in the 3xTg-AD mouse brain markedly exacerbated mitochondrial dysfunction. Collectively, the data indicate significant mitochondrial dysfunction occurs early in AD pathogenesis in a female AD mouse model. Mitochondrial dysfunction provides a plausible mechanistic rationale for the hypometabolism in brain that precedes AD diagnosis and suggests therapeutic targets for prevention of AD.
                Bookmark

                Author and article information

                Contributors
                (View ORCID Profile)
                Journal
                Experimental Neurology
                Experimental Neurology
                Elsevier BV
                00144886
                March 2020
                March 2020
                : 325
                : 113161
                Article
                10.1016/j.expneurol.2019.113161
                6957126
                31881218
                7d9a6fa3-5acc-4ccd-a2f5-9297961c4e5c
                © 2020

                https://www.elsevier.com/tdm/userlicense/1.0/

                History

                Comments

                Comment on this article